Maelstrom Research Staging | RECOVER_Phase_1_COVID19_group

RECOVER_Phase_1_COVID19_group_Reinfection

Networks -

Variables -

Associated study RECOVER Contingency Table

Population

RECOVER - Phase 1 COVID-19 group

The population is composed of healthcare workers that have tested positive for COVID-19 and that, upon initial infection, are symptomatic or not.

Selection Criteria

Newborns

Twins

Countries

Canada

Territory

Ethnic Origin

Health Status

Participants must have had a PCR-confirmed COVID-19 infection prior to enrollment.

Other Criteria

Exclusion criteria:

At the time of recruitment are no longer working in a healthcare setting or have been furloughed as a preventive measure;

Are not fluent in French or English;

Have no access to a cell phone or internet, as follow-up will be done through text messages and emails.

Are participating in a clinical trial for preventive treatment of COVID-19 {e.g., high dose Vitamin D (>2000IU/day or ≥10,000IU/wk), colchicine}, who are still on treatment upon recruitment. Can be included if taken for other reasons.

Have received a COVID-19 vaccine prior to their enrolment in the study.

Supplementary Information about selection criteria

Of 570 participants, the majority are female (83.0%) and Caucasian (79.3%). The median age is 42. Most worked in acute-care hospitals (54.1%) or public long-term care facilities (24.4%). The most commonly reported profession is nurse/paramedic (40.4%), followed by patient care attendant (12.8%) and physician/medical resident (11.8%).

Recruitment

Sources of recruitment

Specific population
Participants from existing studies

Specific Population

Members of an association

Supplementary Information

Recruitment is done in vaccine study centers (MUHC/CHUSJ Vaccine Center), with additional recruitment in hospitals (CHUM, JGH, MUHC) or CHSLDs, near/where participants work.

Participants are also recruited from the large case-control study conducted by the INSPQ.

Participants from Existing Studies

Santé Publique du Québec (INSPQ) (G. De Serres) case-control study

Number of Participants

Number of Participants: 570
Number of Participants with Biological Samples: 570

More info

Data Collection Event

RECOVER - Phase 1 COVID-19 group - Reinfection

Information is collected for reinfected participants about the date of COVID-19 reinfection, location of reinfection (workplace, public transit, household member, restaurant/bar), source of reinfection (colleague, child, friend, parent, household family member, patient), symptomatology (date, duration, type of symptoms), hospitalizations, and interventions (oxygen therapy, mechanical ventilation). Blood, saliva, and nasopharyngeal swab samples are collected for reinfected participants.

More info

Collected Dataset / RECOVER_Phase_1_COVID19_group_Reinfection

RECOVER_Phase_1_COVID19_group_Reinfection

Population

RECOVER - Phase 1 COVID-19 group

Data Collection Event

RECOVER - Phase 1 COVID-19 group - Reinfection

Files

Variables Classifications